Clinical Significance of Suboptimal Hormonal Levels in Men With Prostate Cancer Treated With LHRH Agonists

Canadian Urological Association Journal - Canada
doi 10.5489/cuaj.540
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Canadian Urological Association Journal

Related search

Cost-Effectiveness Analysis of LHRH Agonists in the Treatment of Metastatic Prostate Cancer in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Impact of Comorbidity on the Outcome in Men With Advanced Prostate Cancer Treated With Docetaxel

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2015English

Comparison of Serum Testosterone Levels in Prostate Cancer Patients Receiving LHRH Agonist Therapy With or Without the Removal of the Prostate

Journal of the Canadian Urological Association
OncologyUrology
2012English

Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer

Journal of Urology
Urology
2011English

Survival in Men With Nonmetastatic Prostate Cancer Treated With Hormone Therapy: A Quantitative Systematic Review

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2007English

Lenalidomide Modulates IL-8 and Anti-Prostate Antibody Levels in Men With Biochemically Recurrent Prostate Cancer

Prostate
OncologyUrology
2011English

Clinical Significance of P53 Alterations in Surgically Treated Prostate Cancers

Modern Pathology
Forensic MedicinePathology
2008English

Cardiovascular Risk During Hormonal Treatment in Patients With Prostate Cancer

Cancer Management and Research
Oncology
2011English

PSA Levels and Prognosis in Patients With Hormone-Refractory Prostate Cancer Treated With Low-Dose Dexamethasone

Japanese Journal of Urology
Urology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy